New Platinum(II) Complexes Affecting Different Biomolecular Targets in Resistant Ovarian Carcinoma Cells

Resistance to platinum‐based anticancer drugs represents an important limit for their clinical effectiveness and one of the most important field of investigation in the context of platinum compounds. From our previous studies, Pt(II) complexes containing the triphenylphosphino moiety have been emerg...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyeraci, Mariafrancesca, Scalcon, Valeria, Folda, Alessandra, Labella, Luca, Marchetti, Fabio, Samaritani, Simona, Rigobello, Maria Pia, Dalla Via, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252049/
https://www.ncbi.nlm.nih.gov/pubmed/33751814
http://dx.doi.org/10.1002/cmdc.202100075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252049/
https://www.ncbi.nlm.nih.gov/pubmed/33751814
http://dx.doi.org/10.1002/cmdc.202100075

Ejemplares similares